Clinical Trial Update: Trial to Evaluate the Efficacy and Safety of KM-819 Treatment to Slow the Progression of Multiple System Atrophy (MSA) [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating KM-819 to slow progression of Multiple System Atrophy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• KM-819 (KM-819)

Snippet

Sponsor: Kainos Medicine Inc. | Conditions: Multiple System Atrophy | Phase 2 | Status: TERMINATED